首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >The CXC chemokine stromal cell-derived factor 1 is not responsible for CD8+ T cell suppression of syncytia-inducing strains of HIV-1
【2h】

The CXC chemokine stromal cell-derived factor 1 is not responsible for CD8+ T cell suppression of syncytia-inducing strains of HIV-1

机译:CXC趋化因子基质细胞衍生因子1不负责抑制HIV-1合胞体诱导株的CD8 + T细胞

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Primary CD8+ T cells from HIV+ asymptomatics can suppress virus production from CD4+ T cells acutely infected with either non-syncytia-inducing (NSI) or syncytia-inducing (SI) HIV-1 isolates. NSI strains of HIV-1 predominantly use the CCR5 chemokine receptor as a fusion cofactor, whereas fusion of T cell line-adapted SI isolates is mediated by another chemokine receptor, CXCR4. The CCR5 ligands RANTES (regulated on activation, normal T cell expressed and secreted), macrophage inflammatory protein 1α (MIP-1α), and MIP-1β are HIV-1 suppressive factors secreted by CD8+ cells that inhibit NSI viruses. Recently, the CXC chemokine stromal cell-derived factor 1 (SDF-1) was identified as a ligand for CXCR4 and shown to inhibit SI strains. We speculated that SDF-1 might be an effector molecule for CD8+ suppression of SI isolates and assessed several SDF-1 preparations for inhibition of HIV-1LAI-mediated cell–cell fusion, and examined levels of SDF-1 transcripts in CD8+ T cells. SDF-1 fusion inhibitory activity correlated with the N terminus, and the α and β forms of SDF-1 exhibited equivalent fusion blocking activity. SDF-1 preparations having the N terminus described by Bleul et al. (Bleul, C.C., Fuhlbrigge, R.C., Casasnovas, J.M., Aiuti, A. & Springer, T.A. (1996) J. Exp. Med. 184, 1101–1109) readily blocked HIV-1LAI-mediated fusion, whereas forms containing two or three additional N-terminal amino acids lacked this activity despite their ability to bind and/or signal through CXCR4. Though SDF-1 is constitutively expressed in most tissues, CD8 T cells contained extremely low levels of SDF-1 mRNA transcripts (<1 transcript/5,000 cells), and these levels did not correlate with virus suppressive activity. We conclude that suppression of SI strains of HIV-1 by CD8+ T cells is unlikely to involve SDF-1.
机译:HIV + 无症状的原代CD8 + T细胞可抑制急性感染非合胞体(NSI)的CD4 + T细胞的病毒产生)或合胞体诱导(SI)HIV-1分离株。 HIV-1的NSI株主要使用CCR5趋化因子受体作为融合辅因子,而适应T细胞系的SI分离株的融合则由另一种趋化因子受体CXCR4介导。 CCR5配体RANTES(受激活,正常T细胞表达和分泌调节),巨噬细胞炎性蛋白1α(MIP-1α)和MIP-1β是CD8 + 细胞分泌的HIV-1抑制因子抑制NSI病毒。最近,CXC趋化因子基质细胞衍生因子1(SDF-1)被确定为CXCR4的配体,并显示出可抑制SI菌株。我们推测SDF-1可能是抑制SI分离物CD8 + 的效应分子,并评估了几种抑制HIV-1LAI介导的细胞间融合的SDF-1制剂,并研究了SDF的水平CD8 + T细胞中的-1转录本。 SDF-1融合抑制活性与N末端相关,并且SDF-1的α和β形式表现出同等的融合阻断活性。 Bleul等人描述的具有N末端的SDF-1制剂。 (Bleul,CC,Fuhlbrigge,RC,Casasnovas,JM,Aiuti,A.&Springer,TA(1996)J. Exp。Med。184,1101-1109)容易阻断HIV-1LAI介导的融合,而含有两种或两种形式的尽管另外三个N末端氨基酸具有通过CXCR4结合和/或通过CXCR4发出信号的能力,但它们却缺乏这种活性。尽管SDF-1在大多数组织中组成性表达,但CD8 T细胞含有极低水平的SDF-1 mRNA转录物(<1转录物/ 5,000细胞),并且这些水平与病毒抑制活性无关。我们得出结论,CD8 + T细胞抑制HIV-1 SI株不太可能涉及SDF-1。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号